{"id":4419,"date":"2021-12-31T13:00:00","date_gmt":"2021-12-31T13:00:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/3619321_CN19321_0"},"modified":"2021-12-31T13:00:00","modified_gmt":"2021-12-31T13:00:00","slug":"i-mab-announces-upcoming-participation-at-january-conferences","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=4419","title":{"rendered":"I-Mab Announces Upcoming Participation at January Conferences"},"content":{"rendered":"<p><span id=\"spanHghlt9116\"><span class=\"xn-location\">SHANGHAI<\/span> and<\/span> <span class=\"xn-location\">GAITHERSBURG, MD<\/span>., Dec.&nbsp;31,&nbsp;2021 \/PRNewswire\/ &#8212; I-Mab (the &#8220;Company&#8221;) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced its participation in the following conferences in <span class=\"xn-chron\">January 2022<\/span>. Details of the conferences and management presentation are as follows:<\/p>\n<p><b>40th Annual J.P. Morgan Healthcare Conference <\/b><\/p>\n<p>Presentation: <span class=\"xn-chron\">Tuesday, January 11, 2022<\/span>, at 4:30&nbsp;p.m. E.S.T. <\/p>\n<p>Presenter: Dr. <span class=\"xn-person\">Jingwu Zang<\/span>, Founder, Chairman, Acting CEO and Director<\/p>\n<p>Webcast link: <a target=\"_blank\" href=\"https:\/\/jpmorgan.metameetings.net\/events\/healthcare22\/sessions\/40371-i-mab-biopharma\/webcast?gpu_only=true&amp;kiosk=true\" rel=\"nofollow noopener\">https:\/\/jpmorgan.metameetings.net\/events\/healthcare22\/sessions\/40371-i-mab-biopharma\/webcast?gpu_only=true&amp;kiosk=true<\/a>&nbsp;&nbsp;The webcast will also be available under &#8220;Event Calendar&#8221; on IMAB&#8217;s IR website at <a target=\"_blank\" href=\"http:\/\/ir.i-mabbiopharma.com\/\" rel=\"nofollow noopener\">http:\/\/ir.i-mabbiopharma.com\/<\/a>&nbsp;.<\/p>\n<p>One-on-one and small group meetings: <span class=\"xn-chron\">January 19-21, 2022<\/span><\/p>\n<p>Management participants: Dr. <span class=\"xn-person\">Jingwu Zang<\/span>, Founder, Chairman, Acting CEO and Director, Dr. <span class=\"xn-person\">Andrew Zhu<\/span>, Director and President, Mr. <span class=\"xn-person\">John Long<\/span>, Director and Chief Financial Officer, Mr. <span class=\"xn-person\">Tianyi Zhang<\/span>, Vice President Investor Relations, Mr. <span class=\"xn-person\">Tyler Ehler<\/span>, Senior Director Investor Relations and <span class=\"xn-person\">Phoebe Peng<\/span>, Associate Director Investor Relations<\/p>\n<p>For more information, please contact your J.P. Morgan representative.<\/p>\n<p><b>Morgan Stanley Virtual China New Economy Summit 2022<\/b><\/p>\n<p>One-on-one and small group meetings: <span class=\"xn-chron\">January 5-7, 2022<\/span><\/p>\n<p>Management participants: Dr. <span class=\"xn-person\">Jingwu Zang<\/span>, Founder, Chairman, Acting CEO and Director, Dr. <span class=\"xn-person\">Andrew Zhu<\/span>, Director and President, Mr. <span class=\"xn-person\">John Long<\/span>, Director and Chief Financial Officer, Mr. <span class=\"xn-person\">Tianyi Zhang<\/span>, Vice President Investor Relations, Mr. <span class=\"xn-person\">Tyler Ehler<\/span>, Senior Director Investor Relations and <span class=\"xn-person\">Phoebe Peng<\/span>, Associate Director Investor Relations<\/p>\n<p>For more information, please contact your Morgan Stanley representative.<\/p>\n<p><b>H.C. Wainwright Virtual BioConnect Conference<\/b><\/p>\n<p>One-on-one and small group meetings: <span class=\"xn-chron\">January 10 &#8211; 13, 2021<\/span><\/p>\n<p>Management participants: Dr. <span class=\"xn-person\">Jingwu Zang<\/span>, Founder, Chairman, Acting CEO and Director, Dr. <span class=\"xn-person\">Andrew Zhu<\/span>, Director and President, Mr. <span class=\"xn-person\">John Long<\/span>, Director and Chief Financial Officer, Mr. <span class=\"xn-person\">Tianyi Zhang<\/span>, Vice President Investor Relations, Mr. <span class=\"xn-person\">Tyler Ehler<\/span>, Senior Director Investor Relations and <span class=\"xn-person\">Phoebe Peng<\/span>, Associate Director Investor Relations<\/p>\n<p>For more information, please contact your H.C.Wainwright representative.<\/p>\n<p><b>UBS Greater China Conference 2022<\/b><\/p>\n<p>One-on-one and small group meetings: <span class=\"xn-chron\">January 11-14, 2022<\/span><\/p>\n<p>Management participants: Dr. <span class=\"xn-person\">Jingwu Zang<\/span>, Founder, Chairman, Acting CEO and Director, Dr. <span class=\"xn-person\">Andrew Zhu<\/span>, Director and President, Mr. <span class=\"xn-person\">John Long<\/span>, Director and Chief Financial Officer, Mr. <span class=\"xn-person\">Tianyi Zhang<\/span>, Vice President Investor Relations, Mr. <span class=\"xn-person\">Tyler Ehler<\/span>, Senior Director Investor Relations and <span class=\"xn-person\">Phoebe Peng<\/span>, Associate Director Investor Relations<\/p>\n<p>For more information, please contact your UBS representative.<\/p>\n<p><b>About I-Mab<\/b><\/p>\n<p>I-Mab (Nasdaq: IMAB) is an innovation-driven global biopharma company focused on the discovery, development and commercialization of novel and highly differentiated biologics for immuno-oncology and autoimmune diseases. The Company&#8217;s mission is to bring transformational medicines to patients around the world through innovation. I-Mab&#8217;s globally competitive pipeline of more than 20 clinical and preclinical-stage drug candidates is driven by its internal discovery and global partnerships for in-licensing, based on the Company&#8217;s Fast-to-Proof-of-Concept and Fast-to-Market development strategies. The Company is progressing from a clinical-stage biotech company into a fully integrated global biopharmaceutical company with cutting-edge R&amp;D capabilities, a world-class GMP manufacturing facility, and commercial capability. I-Mab has established its global footprint in <span class=\"xn-location\">Shanghai<\/span> (headquarters), <span class=\"xn-location\">Beijing<\/span>, <span class=\"xn-location\">Hangzhou<\/span>, <span class=\"xn-location\">Guangzhou<\/span>, Lishui and <span class=\"xn-location\">Hong Kong<\/span> in <span class=\"xn-location\">China<\/span>, and <span class=\"xn-location\">Maryland<\/span> and <span class=\"xn-location\">San Diego<\/span> in <span class=\"xn-location\">the United States<\/span>. For more information, please visit&nbsp;<a target=\"_blank\" href=\"http:\/\/ir.i-mabbiopharma.com\/\" rel=\"nofollow noopener\">http:\/\/ir.i-mabbiopharma.com<\/a>&nbsp;and follow I-Mab on&nbsp;<a target=\"_blank\" href=\"https:\/\/www.linkedin.com\/company\/i-mab\/\" rel=\"nofollow noopener\">LinkedIn<\/a>,&nbsp;<a target=\"_blank\" href=\"https:\/\/twitter.com\/IMabBiopharma\" rel=\"nofollow noopener\">Twitter<\/a>, and&nbsp;<a target=\"_blank\" href=\"https:\/\/mp.weixin.qq.com\/mp\/profile_ext?action=home&amp;__biz=MzI1MDM5MjIyOQ==\" rel=\"nofollow noopener\">WeChat<\/a>.<\/p>\n<p><b>For more information, please contact:<\/b><\/p>\n<p><b>I-Mab Contacts<\/b><\/p>\n<p><b>Investor Inquiries:<\/b><\/p>\n<p>The Piacente Group, Inc.<br \/><span class=\"xn-person\">Emilie Wu<\/span><br \/>E-mail: <a target=\"_blank\" href=\"mailto:emilie@thepiacentegroup.com\" rel=\"nofollow noopener\">emilie@thepiacentegroup.com<\/a><br \/>Office line: + 86 21 6039 8363<\/p>\n<p id=\"PURL\"><img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CN19321&amp;sd=2021-12-31\"> View original content:<a id=\"PRNURL\" rel=\"nofollow noopener\" href=\"https:\/\/www.prnewswire.com\/news-releases\/i-mab-announces-upcoming-participation-at-january-conferences-301452230.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/i-mab-announces-upcoming-participation-at-january-conferences-301452230.html<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SHANGHAI and GAITHERSBURG, MD., Dec.&nbsp;31,&nbsp;2021 \/PRNewswire\/ &#8212; I-Mab (the &#8220;Company&#8221;) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced its participation in the following conferences in January 2022. Details of the conferences and management presentation are as follows: 40th Annual J.P. Morgan Healthcare Conference Presentation: Tuesday, [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":4420,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-4419","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>I-Mab Announces Upcoming Participation at January Conferences - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=4419\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"I-Mab Announces Upcoming Participation at January Conferences - My Blog\" \/>\n<meta property=\"og:description\" content=\"SHANGHAI and GAITHERSBURG, MD., Dec.&nbsp;31,&nbsp;2021 \/PRNewswire\/ &#8212; I-Mab (the &#8220;Company&#8221;) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced its participation in the following conferences in January 2022. Details of the conferences and management presentation are as follows: 40th Annual J.P. Morgan Healthcare Conference Presentation: Tuesday, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=4419\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-31T13:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2021\/12\/i-mab-announces-upcoming-participation-at-january-conferences.png\" \/>\n\t<meta property=\"og:image:width\" content=\"16\" \/>\n\t<meta property=\"og:image:height\" content=\"16\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4419#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4419\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"I-Mab Announces Upcoming Participation at January Conferences\",\"datePublished\":\"2021-12-31T13:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4419\"},\"wordCount\":572,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4419#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/i-mab-announces-upcoming-participation-at-january-conferences.png\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4419\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4419\",\"name\":\"I-Mab Announces Upcoming Participation at January Conferences - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4419#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4419#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/i-mab-announces-upcoming-participation-at-january-conferences.png\",\"datePublished\":\"2021-12-31T13:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4419#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4419\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4419#primaryimage\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/i-mab-announces-upcoming-participation-at-january-conferences.png\",\"contentUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/i-mab-announces-upcoming-participation-at-january-conferences.png\",\"width\":16,\"height\":16},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=4419#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"I-Mab Announces Upcoming Participation at January Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"I-Mab Announces Upcoming Participation at January Conferences - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=4419","og_locale":"en_US","og_type":"article","og_title":"I-Mab Announces Upcoming Participation at January Conferences - My Blog","og_description":"SHANGHAI and GAITHERSBURG, MD., Dec.&nbsp;31,&nbsp;2021 \/PRNewswire\/ &#8212; I-Mab (the &#8220;Company&#8221;) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced its participation in the following conferences in January 2022. Details of the conferences and management presentation are as follows: 40th Annual J.P. Morgan Healthcare Conference Presentation: Tuesday, [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=4419","og_site_name":"My Blog","article_published_time":"2021-12-31T13:00:00+00:00","og_image":[{"width":16,"height":16,"url":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2021\/12\/i-mab-announces-upcoming-participation-at-january-conferences.png","type":"image\/png"}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=4419#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=4419"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"I-Mab Announces Upcoming Participation at January Conferences","datePublished":"2021-12-31T13:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=4419"},"wordCount":572,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=4419#primaryimage"},"thumbnailUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2021\/12\/i-mab-announces-upcoming-participation-at-january-conferences.png","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=4419","url":"https:\/\/transmediavictoria.net.au\/?p=4419","name":"I-Mab Announces Upcoming Participation at January Conferences - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=4419#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=4419#primaryimage"},"thumbnailUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2021\/12\/i-mab-announces-upcoming-participation-at-january-conferences.png","datePublished":"2021-12-31T13:00:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=4419#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=4419"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=4419#primaryimage","url":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2021\/12\/i-mab-announces-upcoming-participation-at-january-conferences.png","contentUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2021\/12\/i-mab-announces-upcoming-participation-at-january-conferences.png","width":16,"height":16},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=4419#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"I-Mab Announces Upcoming Participation at January Conferences"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/4419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4419"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/4419\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/media\/4420"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}